Literature DB >> 19330038

The effects of delayed and frequency shifted feedback on speakers with Parkinson's Disease.

Bettina Brendel1, Anja Lowit, Peter Howell.   

Abstract

Delayed auditory feedback (DAF) has been assessed as a rate reduction and intelligibility enhancing tool in patients with Parkinson's Disease (PD) for some time. However, there are contradictory results in the literature regarding the success of this device. Also, little is known about the effects of DAF on speech other than influences on speech rate and intelligibility. Frequency shifted feedback (FSF) is known to produce more natural sounding speech than DAF and to improve the fluency of persons who stutter. However, there are currently no studies reporting how PD speakers perform under FSF.The aim of this study was to investigate the effects of both types of altered feedback on the speech of PD and control participants on a broad range of measures. The performance of 16 PD speakers and 11 control speakers in a reading task under DAF, FSF and no altered feedback (NAF) are reported in this paper.The results showed that all groups responded to altered feedback in a similar way and showed a prominent reduction of speech rate. The conditions evoked changes in pause frequency (increases), loudness levels (increases), pitch variation (increases) and intelligibility and naturalness (decreases) for all or some of the groups. Few effects could be observed on articulation/pause time ratio, pause duration, pitch range, and speech rhythm. Previous reports on differences in susceptibility of PD speaker to altered feedback were confirmed and some speakers benefited from the system despite the negative group results for intelligibility and naturalness. In general, FSF resulted in performance closer to the NAF state than DAF on all variables, and for those PD speakers who benefited from altered feedback, the FSF condition evoked the greatest improvement.

Entities:  

Year:  2004        PMID: 19330038      PMCID: PMC2661057     

Source DB:  PubMed          Journal:  J Med Speech Lang Pathol        ISSN: 1065-1438


  6 in total

1.  Quantitative characterizations of speech rhythm: syllable-timing in Singapore English.

Authors:  L E Ling; E Grabe; F Nolan
Journal:  Lang Speech       Date:  2000 Oct-Dec       Impact factor: 1.500

2.  Prosodic variation across sampling tasks in normal and dysarthric speakers.

Authors:  A Lowit-Leuschel; G J Docherty
Journal:  Logoped Phoniatr Vocol       Date:  2001       Impact factor: 1.487

3.  Changes in voice level caused by several forms of altered feedback in fluent speakers and stutterers.

Authors:  P Howell
Journal:  Lang Speech       Date:  1990 Oct-Dec       Impact factor: 1.500

4.  Speech disorder in parkinsonism--usefulness of delayed auditory feedback in selected cases.

Authors:  A W Downie; J M Low; D D Lindsay
Journal:  Br J Disord Commun       Date:  1981-09

5.  Direct magnitude estimation and interval scaling of hypernasality.

Authors:  Tara L Whitehill; Alice S Y Lee; Joyce C Chun
Journal:  J Speech Lang Hear Res       Date:  2002-02       Impact factor: 2.297

6.  Effects of delayed auditory feedback and frequency-shifted feedback on speech control and some potentials for future development of prosthetic aids for stammering.

Authors:  Peter Howell
Journal:  Stammering Res       Date:  2004-04-01
  6 in total
  3 in total

1.  Sensorimotor adaptation of speech in Parkinson's disease.

Authors:  Fatemeh Mollaei; Douglas M Shiller; Vincent L Gracco
Journal:  Mov Disord       Date:  2013-07-16       Impact factor: 10.338

2.  The effects of delayed auditory and visual feedback on speech production.

Authors:  Jennifer Chesters; Ladan Baghai-Ravary; Riikka Möttönen
Journal:  J Acoust Soc Am       Date:  2015-02       Impact factor: 1.840

3.  Rhythmic performance in hypokinetic dysarthria: Relationship between reading, spontaneous speech and diadochokinetic tasks.

Authors:  Anja Lowit; Agata Marchetti; Stephen Corson; Anja Kuschmann
Journal:  J Commun Disord       Date:  2018-02-15       Impact factor: 2.288

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.